💡Core conceptThe big idea
- AF is an irregularly irregular rhythm where the atria quiver instead of contracting.
- The danger is clot formation → stroke, so the priority is stroke prevention, then rate/rhythm.
? Quick check
What is the main long-term risk that drives AF management?
Show answer
Stroke from atrial clot — which is why anticoagulation comes first.
⚡The ruleWho to anticoagulate
- Score stroke risk with CHA₂DS₂-VASc.
- Anticoagulate if ≥2 (men) or ≥3 (women). Assess bleeding risk with ORBIT.
? Quick check
A man with CHA₂DS₂-VASc of 2 — anticoagulate?
Show answer
Yes. Offer anticoagulation; a DOAC is first-line.
🧠How to picture itWhich anticoagulant
- DOAC first-line (apixaban, rivaroxaban, edoxaban, dabigatran).
- Warfarin only for mechanical valves or moderate–severe mitral stenosis. Aspirin has no role.
? Quick check
Patient with a mechanical heart valve and AF — DOAC or warfarin?
Show answer
Warfarin — DOACs are contraindicated in mechanical valves.
🎯Why it mattersRate vs rhythm
- Usually rate control first (beta-blocker or rate-limiting CCB).
- Lenient target <110 if asymptomatic; aim tighter only if symptoms persist.
? Quick check
Asymptomatic AF, resting HR 96, normal heart. Change treatment?
Show answer
No — lenient rate control (<110) is acceptable.
🧠How to picture itScore before you anticoagulate
- CHA₂DS₂-VASc for stroke risk; ORBIT for bleeding risk.
- Anticoagulate if score ≥2 (men) / ≥3 (women); don’t withhold for a high bleeding score alone.
? Quick check
Which score now replaces HAS-BLED for bleeding risk in NG196?
Show answer
ORBIT.
🎯Why it mattersDOAC dosing trap
- Reduce apixaban to 2.5 mg BD if ≥2 of: age ≥80, weight ≤60 kg, creatinine ≥133.
- Avoid DOACs in mechanical valves / moderate-severe mitral stenosis — use warfarin.
? Quick check
Which valve situation needs warfarin, not a DOAC?
Show answer
Mechanical valve (and moderate–severe mitral stenosis).
⚡The ruleBleeding risk: ORBIT (and HAS-BLED)
- NICE NG196 now uses the ORBIT score for bleeding risk (it outperformed HAS-BLED).
- HAS-BLED (Hypertension, Abnormal renal/liver, Stroke, Bleeding, Labile INR, Elderly, Drugs/alcohol) is still widely known and used elsewhere — recognise it, but NICE prefers ORBIT.
- A high bleeding score is not a reason to withhold anticoagulation — it prompts you to correct modifiable factors (BP, alcohol, NSAIDs).
? Quick check
Which bleeding-risk score does NICE NG196 now recommend for AF, and what replaced it?
Show answer
ORBIT is now recommended; it replaced HAS-BLED. A high score modifies risk factors, it doesn’t stop anticoagulation.